Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G10 | O15496 | 1/20 | 0.53 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.53 |
| ▸ | PARP10 | Q53GL7 | 4/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | VNN1 | O95497 | 1/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.45 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1402894 | 0.83 | KMT2A (0.60) | EPHX2NR1H4IDO1CA2CYP3A4 | |
| SCHEMBL10561443 | 0.83 | MPO (0.59) | IDO1CA2CYP3A4MAPTKMT2A | |
| SCHEMBL10209044 | 0.81 | PLA2G10 (0.52) | PLA2G10PLA2G2AEPHX2NR1H4PARP10 | |
| SCHEMBL3882642 | 0.81 | PLA2G10 (0.57) | PLA2G10PLA2G2AEPHX2NR1H4PARP10 | |
| SCHEMBL19091139 | 0.81 | PLA2G10 (0.52) | PLA2G10PLA2G2AEPHX2NR1H4PARP10 | |
| SCHEMBL16162038 | 0.79 | EPHX2 (0.58) | PLA2G10PLA2G2AEPHX2NR1H4PARP10 | |
| SCHEMBL18235891 | 0.78 | EPHX2 (0.53) | PLA2G10PLA2G2AEPHX2NR1H4PARP10 | |
| SCHEMBL5929617 | 0.78 | KMT2A (0.70) | PLA2G10PLA2G2AEPHX2NR1H4PARP10 | |
| SCHEMBL11869981 | 0.78 | ALDH1A1 (0.60) | PLA2G10PLA2G2AEPHX2NR1H4PARP10 | |
| SCHEMBL3306120 | 0.78 | ADH1B (0.53) | PLA2G10PLA2G2AEPHX2NR1H4PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163488-A1 | CONJUGATION METHOD INVOLVING A TRANSGLUTAMINASE AT THE FC REGION COMPRISING A TRIMMED N-GLYCAN | BLUE OWL OPPORTUNISTIC MASTER FUND I, L.P. (FORMERLY KNOWN AS OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.) | 2025-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163488-A1 | CONJUGATION METHOD INVOLVING A TRANSGLUTAMINASE AT THE FC REGION COMPRISING A TRIMMED N-GLYCAN | ENGASE, B3GAT3, FCGR2A | PLA2G10 2200/4885PLA2G2A 1409/4885EPHX2 1721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.